Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.

Saved in:
Bibliographic Details
Title: Comparison of a commercial modified factor VIII bethesda inhibitor assay to current factor VIII inhibitor assay methods in a multicenter trial.
Authors: Mindiola Romero AE; Department of Pathology, University of New Mexico, Albuquerque, New Mexico.; North American Specialized Coagulation Laboratory Association, Rochester, Minnesota, USA., Marlar RA; Department of Pathology, University of New Mexico, Albuquerque, New Mexico.; North American Specialized Coagulation Laboratory Association, Rochester, Minnesota, USA., Rollins-Raval MA; Department of Pathology and Laboratory Medicine, The University of Vermont, Burlington, Vermont, USA.; North American Specialized Coagulation Laboratory Association, Rochester, Minnesota, USA., Burns I; Precision BioLogic Inc., Dartmouth, Nova Scotia, Canada., Plumhoff EA; North American Specialized Coagulation Laboratory Association, Rochester, Minnesota, USA.
Corporate Authors: laboratory participants, NASCOLA (North American Specialized Coagulation Laboratory Association)
Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2026 Jul 01; Vol. 37 (5), pp. 207-219. Date of Electronic Publication: 2026 May 03.
Publication Type: Journal Article; Comparative Study; Multicenter Study
Journal Info: Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5733 (Electronic) Linking ISSN: 09575235 NLM ISO Abbreviation: Blood Coagul Fibrinolysis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5733
DOI:10.1097/MBC.0000000000001433